SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-017354
Filing Date
2024-05-01
Accepted
2024-05-01 08:00:42
Documents
15
Period of Report
2024-05-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41516
2 ex99-1.htm EX-99.1 16545
3 ex99-1_001.jpg GRAPHIC 13273
  Complete submission text file 0001493152-24-017354.txt   252968

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cocp-20240501.xsd EX-101.SCH 3036
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cocp-20240501_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cocp-20240501_pre.xml EX-101.PRE 22373
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3546
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 24900129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)